2 not yet recruiting, 1 recruiting, 1 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Not yet recruiting 1, Recruiting 1, Withdrawn 1 |
Follow Letrozole 2.5Mg Tab: new trials by email Literature Review of Letrozole 2.5Mg Tab trials Research Report on Letrozole 2.5Mg Tab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy Methotrexate (drug), Letrozole 2.5Mg Tab - Ectopic Pregnancy | Phase 2 | Not yet recruiting | Kafrelsheikh University | 70 | 2026-06-01 | 2026-06-03 |
| Neoadjuvant Treatment of Breast Cancer Tamoxifen, Goserelin, Letrozole 2.5Mg Tab - Breast Cancer | Not yet recruiting | National Institute of Oncology, Hungary | 300 | 2022-03-01 | 2021-11-23 | |
| Combined Immunotherapies in Metastatic ER+ Breast Cancer Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions), Letrozole 2.5Mg Tab, Palbociclib 125mg - Breast Cancer | Phase 2 | Recruiting | Weill Medical College of Cornell University | 102 | 2020-11-12 | 2025-12-15 |
| CIMER: Combined Immunotherapies in Metastatic ER+ Breast Cancer Stereotactic Body Radiation Therapy (SBRT) (50GY in 5 fractions), Letrozole 2.5Mg Tab, Palbociclib 125mg - Breast Cancer | Phase 2 | Withdrawn | Weill Medical College of Cornell University | 2020-03-04 | 2020-09-21 |
Breast Neoplasms (3) · Pregnancy, Ectopic (1)
Weill Medical College of Cornell University (2) · Kafrelsheikh University (1) · National Institute of Oncology, Hungary (1)
Egypt (1) · Hungary (1) · United States (1)
Silvia Formenti, M.D. (2) · Gabor Rubovszky (1) · Walid Mamdouh Atallah, OBGYN Professor (1)